Company / Cash per Share
BioRestorative Therapies, Inc. Cash per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.22
FY2025
5-year range
$0.12 / $29.39
FY2021-FY2025
Trend
+87.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $0.22.
Based on SEC 10-K filings.
0.22 in FY2025 with a 3-year CAGR of -23.4%.
Declined from $0.24 to $0.22 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -23.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 87.6% year-over-year.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | +87.6% |
| FY2024 | $0.12 | -51.6% |
| FY2023 | $0.24 | -50.6% |
| FY2022 | $0.49 | -98.3% |
| FY2021 | $29.39 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026